Evaluations and CME Certificates

Online evaluations will be available through March 19, 2023 (please email evals@HealioLive.com if you need assistance this year or with obtaining a certificate from a previous year.

Target Audience

This meeting has been designed for ophthalmologists and residents/students.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Detail new trends in practice management and how they can improve overall patient care.
  • Summarize updates in subspecialty areas such as neuro-ophthalmology, oculoplastics, and strabismus.
  • Examine new evidence and innovations pertaining to the medical and surgical management of retinal disorders including the use of imaging, managing age-related macular degeneration, diabetic eye disease, uveitis, and retinal toxicity and detachments.
  • Review the latest information about diagnostics, medical, and surgical management of glaucoma including new medications, drug delivery, and minimally invasive as well as combined cataract surgery.
  • Assess new technology and trends in refractive cataract and cornea surgery including IOLs, astigmatism and presbyopia management, the use of LASIK and SMILE, and lens extractions.
  • Examine case presentations related to the medical and surgical management of corneal conditions.
  • Review recent evidence-based literature and papers pertaining to ocular surface, dry eye, and lid margin disease, crosslinking, and cataract surgery.
  • Evaluate current controversies in cornea including the use of crosslinking in keratoconus, managing moderate glaucoma with toxic medicamentosa, and best surgical options for visually significant cataract.
  • Assess new trends and case presentations in cataract surgery including the use of intraocular devices and procedures, IOL technology and techniques, phacoemulsification, management of complications, patient interactions, and incorporating ergonomics and efficiency.

Telling It Like It Is 2023 is supported, in part, by educational grants from Bausch + Lomb; Dompé US, Inc.; Genentech, a member of the Roche Group; Horizon Therapeutics USA, Inc.; Tarsus Pharmaceuticals, Inc.; STAAR Surgical; and Thea Pharma.

This continuing education activity is provided by

ACCREDITATION: Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 28 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INTERNATIONAL NOTICE: This educational activity is designated for AMA PRA Category 1 Credit(s)™ for all US physicians. US physicians will receive a CME certificate and non-US physicians should contact their respective organizations for reciprocity of credit.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to mitigate and disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.